Answers are grounded in this paper and cite their sources.
Dolutegravir Sodium, a drug used to treat HIV infection, is the primary focus of the current study, as is its development and assessment in rapid disintegrating tablets (HIV).Using the physical approach and the kneading method, we formulated Dolutegravir Sodium as a solid dispersion in an effort to improve its solubility and dissolution rate.The adjusted solid dispersions were then used in the direct compression procedure to create orodispersable tablets with the addition of superdisintegrants such sodium starch glycolate and crospovidone.Dolutegravir Sodium, Sodium Starch Glycolate, and Crospovidone were all subjected to FTIR examinations to characterize their respective purity levels, and the resulting F6 formulation was found to have the best overall profile.The studies demonstrated that there was no interaction between the medication and the excipient.Dolutegravir Sodium tablets made utilising optimal solid dispersions (DK2) with PEG 6000 & Crospovidone as superdisintegrant were shown to be ideal for quick dispersion and for enhancing dissolving rate, which in turn boosts bioavailability, according to the study.
No takes yet. Share an insight, caveat, or question.
Balakrishna et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: